DIAGAST SAS of Loos at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers OEM

DIAGAST SAS

251, avenue Eugène Avinée, Parc Eurasanté, 59120 Loos
France
Telephone +33 3 20965353
Fax +33 3 20965354
communication@diagast.com

This company is co-exhibitor of
Business France SA

Hall map

MEDICA 2018 hall map (Hall 3): stand H74

Fairground map

MEDICA 2018 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.03  Haematology / histology / cytology testing
  • 03.03.03  Immunohaematology testing, blood grouping

Our products

Product category: Immunohaematology testing, blood grouping

DISCOVERING ONYX® AT ISBT TORONTO

On the occasion of the 30th anniversary of DIAGAST at ISBT Toronto 2018, we have revealed ONYX®, our new automated system for immunohematology testing. ONYX® comes as a result of a 5-year extensive development of the latest patented M-TRAP® Technology and has been designed to meet the needs of small and mid-size laboratories.

Powered by M-TRAP® technology, it gives the shortest time to results of the market. It is based on a strong robustness through reduced number of mechanical parts and a predictive maintenance. Associated with the optimized cartridge format, the whole solution provides cost-efficiency to laboratories.

ONYX® is an automated system that gives more benefits with less. LESS includes all aspects: STAT, size of machine, lab space, mechanical parts, breakdowns, waste, training…

First results for ABO-RH1, RH-KEL1 and antibody screening are obtained in 15 minutes instead of 35 minutes for other analyzers

Optimized waiting time during the test processing leading to shorter time to results. Some other analyzers lose 10 minutes minimum because of centrifugation and other non-optimized process.

A machine to machine communication will allow a predictive maintenance to replace the spare parts before they breakdown.

Only 1 shaking incubator is added in ONYX® compared to several incubators and centrifuges placed in other systems. This reduces risk of breakdown, cost and settings contributing to higher robustness.

1 cartridge contains 36 wells and is equivalent to 6 gel cards. It’s an optimized and eco-friendly format for transport, storage leading to the volume reduction of waste.
 
ONYX® is revolutionizing the immunohematology testing thanks to the disruptive M-TRAP® Technology and adapts to the routine activity of the laboratories.

More Less

Product category: Immunohaematology testing, blood grouping

ABD PAD®: 3 STEPS MANUAL BLOOD GROUPING IN 30 SECONDS

ABD PAD® by DIAGAST is an innovative IVDMD (In Vitro Diagnostic Medical Device) for manual ABO/RhD blood group confirmation of donors and recipients. It needs only 3 steps to perform a blood group test within 30 seconds in a safe and standardized way.

It is a ready-to-use pad based on the latest technology M-TRAP® patented by DIAGAST, a breakthrough in manual blood grouping.

PAD ® products use the M-TRAP® technology which is based on the immobilization of antibodies covalently bounded to a porous membrane. Only the red blood cells having the corresponding antigen are fixed into the membrane revealing immediately the reaction.

More Less

Product category: Immunohaematology testing, blood grouping

QWALYS® 3 EVO: NEW GENERATION

As an international expert in the transfusion field, DIAGAST is listening to your needs to innovate and continuously improving its products. You already know QWALYS®’s high throughput, loading capacity and the advantages of E.M.® Technology. Nowadays, QWALYS® is reinventing itself and, for its new generation called QWALYS® 3 EVO, presents new features:

STAT function

Thanks to a software management which assigns urgent factor, STAT samples will be given priority and will have an optimal time to result. Even if the system is operating, routine activity will be delayed to give priority to the STAT sample. Without any analysis, sample and reagents losses and no technician intervention required, the routine will be carried on after treatment of the STAT sample.

Dynamic scheduler

In order to enhance throughput, time to result and improve batch management QWALYS® 3 EVO has now a dynamic scheduler. Hence, STAT samples have priority over others and the scheduler has been optimized to increase its fluidity and reactivity. QWALYS® 3 EVO is even more flexible regarding analysis management whether working with batches or “on-the-fly”.

New user interface

Known by its users as being user-friendly, the QWALYS Data Software (QDS) displays a new design while keeping its key features. The upgrade of QDS provides new functions required by regulation entities (accreditation) but also new options meeting laboratories’ needs.

More Less

About us

Company details

INNOVATE AND ACT IN THE WORLD FOR OPTIMUM TRANSFUSION SOLUTIONS
 
Receiving blood is receiving life. DIAGAST’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable.

Over the last 30 years, DIAGAST has developed an unique expertise and know-how in the transfusion sector. Theses values allow the healthcare professionals to insure the total transfusional compatibility between receivers and donors. Thus DIAGAST has combined biology with information technology, to make its equipment evolving in parallel with the best of the new technology.

DIAGAST focuses on the following 4 strategic axes:

CREATOR OF TAILOR-MADE IMMUNOHAEMATOLOGY SOLUTIONS
Our company develops, produces and markets reagents and automated systems (QWALYS) for the blood grouping determination. Thanks to its mastering of the value chain (from R&D to the installation of solutions including customer training) DIAGAST is able to offer reliable solutions tailored to the needs and requirements of its customers.

INNOVATOR IN BIOTECHNOLOGIES
In a domain of activity where the last real technological innovation proposed by all of our competitors goes back to 1993, DIAGAST through its R & D department always looking for more performance and safety, features breakthrough techniques and innovates by new technologies such as EM® Technology launched in 2004 and Haem Trap launched in 2012 .

SUPPLIER TO THE MAJOR IH COMPANIES
Its large production capacity (a wide range of "FDA approved" fermentors, a portfolio of over 40 clones) and renowned and recognized know-how allow DIAGAST to provide without failing its customers but also its competitors.

COMMITED TO A SUSTAINABLE DEVELOPMENT POLICY
DIAGAST promotes a CSR policy (Corporate Social Responsability) to select its suppliers, to educates its employees (eco-behaviour guide, pro-senior employment,...) and to organize events internally and externally.

More Less